Pharmaceuticals Canada said it is “extremely disappointed” that negotiations for Pluvicto, a treatment for patients ...

Fitting in a workout after a long day of sitting at a desk might not be enough to compensate for the impacts of sedentary ...

The project, which includes partners Onyx Equities, Russo Development and Related Fund Management, will introduce new, Class ...

AstraZeneca and GSK fell as the president-elect named Kennedy as his pick for the role overseeing the US's rules on medicine, ...

When the healthcare sector sneezes, European investors catch a cold. Healthcare is the single biggest sector in the Stoxx ...

Spherix has been tracking the C3G market for over four years in both the U.S. and Europe. The studies have provided meaningful insights into physician perceptions of unmet needs and expectations for ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...

Strategos founder Gary Hamel, Harvard leadership professor Amy Edmondson, former AT&T Business CEO Anne Chow and The CFO ...

Reversing an earlier decision, European regulators recommended that the Alzheimer’s therapy Leqembi should be approved ...

Boston Pharmaceuticals has linked its metabolic dysfunction-associated steatohepatitis (MASH) prospect to improved outcomes ...

With multiple drugmakers already announcing a slew of radiopharmaceutical moves this year, France’s Orano Med is doubling ...